168 related articles for article (PubMed ID: 11192143)
1. Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study.
Gutierrez MM; Abramowitz W
Clin Ther; 2000 Dec; 22(12):1525-32. PubMed ID: 11192143
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of two 40 mg tablet formulations of citalopram using a new amperometric detection technique.
Al-Ghazawi M; Tutunji M; Mohsen M; Najjar S
Int J Clin Pharmacol Ther; 2007 May; 45(5):300-6. PubMed ID: 17542353
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine oral solution is bioequivalent to paroxetine tablets--advantages of the solution.
van den Tweel ER; Relleke M; Muniz Piniella P
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):611-6. PubMed ID: 18077927
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. Single- and multiple-dose pharmacokinetics and tolerability of a paroxetine controlled-release tablet in healthy Chinese subjects
.
Chen R; Shen K; Hu P
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):231-236. PubMed ID: 27936523
[TBL] [Abstract][Full Text] [Related]
8. The perception and pharmacokinetics of a 20-mg dose of escitalopram orodispersible tablets in a relative bioavailability study in healthy men.
Nilausen DØ; Zuiker RG; van Gerven J
Clin Ther; 2011 Oct; 33(10):1492-502. PubMed ID: 21999886
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects.
Søgaard B; Mengel H; Rao N; Larsen F
J Clin Pharmacol; 2005 Dec; 45(12):1400-6. PubMed ID: 16291715
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of two brands of citalopram 40 mg tablets after single oral administration to healthy volunteers.
Mendoza L; Hajdúch M; Kekulová H; Svobodová X; Mihál V; Svoboda M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):169-72. PubMed ID: 16170406
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.
Chenu F; Batten LA; Zernig G; Ladstaetter E; Hébert C; Blier P
J Clin Psychiatry; 2009 Jul; 70(7):958-66. PubMed ID: 19653973
[TBL] [Abstract][Full Text] [Related]
13. A bioequivalence study of citalopram based on quantification by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry.
Mendes GD; Borges NC; Pereira Ados S; Mendes FD; Barrientos-Astigarraga RE; De Nucci G
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):389-98. PubMed ID: 16119514
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
Homero de Souza Filho J; Bonifácio FN; Bedor DC; Ramos VL; de Sousa CE; Sardón LL; Gonçalves TM; Moreira RC; Leal LB; de Santana DP
Clin Ther; 2010 Nov; 32(12):2088-96. PubMed ID: 21118744
[TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetics of citalopram in young and elderly subjects.
Gutierrez M; Abramowitz W
Pharmacotherapy; 2000 Dec; 20(12):1441-7. PubMed ID: 11130216
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of two formulations of escitalopram.
Almeida S; Pedroso P; Filipe A; Neves RI; Tanguay M; Torns A
Arzneimittelforschung; 2012 Jul; 62(7):307-12. PubMed ID: 22628062
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
